Joseph Sasadeusz

Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study

Emma Foster, Michael J Malloy, Vilija G Jokubaitis, C David H Wrede, Helmut Butzkueven, Joe Sasadeusz, Sharon Van Doornum, Finlay Macrae, Gary Unglik, Julia ML Brotherton, Anneke van der Walt

Journal article  |  2020  |  PLOS ONE

BACKGROUND: Autoimmune conditions (AICs) and/or their treatment may alter risk of human papilloma virus (HPV) infection and female..

Review article: prevention, diagnosis and management of COVID-19 in the IBD patient

Aysha H Al-Ani, Ralley E Prentice, Clarissa A Rentsch, Doug Johnson, Zaid Ardalan, Neel Heerasing, Mayur Garg, Sian Campbell, Joe Sasadeusz, Finlay A Macrae, Siew C Ng, David T Rubin, Britt Christensen

Journal article  |  2020  |  Alimentary Pharmacology & Therapeutics

BACKGROUND: The current COVID-19 pandemic, caused by SARS-CoV-2, has emerged as a public health emergency. All nations are serious..

Using telehealth to improve access to hepatitis C treatment in the direct-acting antiviral therapy era

Thomas R Schulz, Kudzai Kanhutu, Joseph Sasadeusz, Sally Watkinson, Beverley-Ann Biggs

Journal article  |  2020  |  Journal of Telemedicine and Telecare

Introduction One-third of the Australian population lives outside major cities and this group has worse health outcomes. Telehealt..

The QuantiFERON Monitor (R) assay is predictive of infection post allogeneic hematopoietic cell transplantation

Abby P Douglas, Lijia Yu, Vijaya Sundararajan, Jeff Szer, David Ritchie, Monica A Slavin, Joe Sasadeusz, Kumar Visvanathan

Journal article  |  2020  |  Transplant Infectious Disease

INTRODUCTION: Following allogeneic hematopoietic stem cell transplantation (alloHCT), excessive immunosuppression can be complicat..

Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure Prophylaxis

Luxi Lal, Kathleen Ryan, Iris Yi Liu, Brian Price, Timmy Lockwood, Ivette Aguirre, Peter Slobodian, Ada Lam, Manoj Vassan, Kie Lim, John Silverii, Joseph Tesoriero, Johnny Phu, Wan Lim, Bharathy Naidoo, Nick Russell, Matthew Rundle, Rowan Sewell, Craig Cooper, Alexander Hardman, et al.

Journal article  |  2019  |  Frontiers in Pharmacology

Screening and Prophylaxis to Prevent Hepatitis B Reactivation Other Populations and Newer Agents

Joe Sasadeusz, Andrew Grigg, Peter D Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G Gish, Kumar Visvanathan

Journal article  |  2019  |  Clinics in Liver Disease

Because of the relatively high prevalence of both hepatitis B infection and various forms of autoimmune inflammatory diseases trea..

Screening and Prophylaxis to Prevent Hepatitis B Reactivation Introduction and Immunology

Joe Sasadeusz, Andrew Grigg, Peter D Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G Gish, Kumar Visvanathan

Journal article  |  2019  |  Clinics in Liver Disease

Current recommendations concerning hepatitis C virus (HBV) reactivation are limited, with nearly all guidelines focused on its occ..

Screening and Prophylaxis to Prevent Hepatitis B Reactivation Transplant Recipients

Joe Sasadeusz, Andrew Grigg, Peter D Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G Gish, Kumar Visvanathan

Journal article  |  2019  |  Clinics in Liver Disease

Organ transplantation is a lifesaving procedure for many patients. To prevent rejection or graft-versus-host disease, recipients r..

Screening and Prophylaxis to Prevent Hepatitis B Reactivation Patients with Hematological and Solid Tumor Malignancies

Joe Sasadeusz, Andrew Grigg, Peter D Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G Gish, Kumar Visvanathan

Journal article  |  2019  |  Clinics in Liver Disease

Patients with malignancies require chemotherapy and other immunosuppressive therapies for treatment. Because of this immunosuppres..

A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries

Nitin Kapoor, Jennifer Audsley, Priscilla Rupali, Joe Sasadeusz, Thomas Paul, Nihal Thomas, Sharon R Lewin

Journal article  |  2019  |  AIDS

: Despite the decreasing total incidence of liver-related deaths, liver disease remains one of the major non-AIDS causes of morbid..

Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement

Joseph Doyle, Michelle Raggatt, Monica Slavin, Sue-Anne McLachlan, Simone I Strasser, Joseph J Sasadeusz, Jessica Howell, Krispin Hajkowicz, Harshal Nandurkar, Anna Johnston, Narin Bak, Alexander J Thompson

Journal article  |  2019  |  Medical Journal of Australia

Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection

Michael W Traeger, Vincent J Cornelisse, Jason Asselin, Brian Price, Norman J Roth, Jeff Willcox, Ban Kiem Tee, Christopher K Fairley, Christina C Chang, Jude Armishaw, Olga Vujovic, Matthew Penn, Pauline Cundill, George Forgan-Smith, John Gall, Claire Pickett, Luxi Lal, Anne Mak, Tim D Spelman, Nguyen Long, et al.

Journal article  |  2019  |  JAMA

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial

Tarik Asselah, Samuel S Lee, Betty B Yao, Nguyen Tuan, Florence Wong, Adam Mahomed, Seng Gee Lim, Armand Abergel, Joe Sasadeusz, Edward Gane, Neddie Zadeikis, Gretja Schnell, Zhenzhen Zhang, Ariel Porcalla, Federico J Mensa, Nguyen Kinh

Journal article  |  2019  |  The Lancet Gastroenterology & Hepatology

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with HCV Genotype 5 or 6 Infection: Final Results of the Endurance-5,6 Study

Samuel S Lee, Tarik Asselah, Betty Yao, Nguyen Tuan, Florence Wong, Adam Mahomed, Seng Gee Lim, Armand Abergel, Joe Sasadeusz, Edward J Gane, Neddie Zadeikis, Preethi Krishnan, Zhenzhen Zhang, Ariel Porcalla, Katia Alves, Federico J Mensa, Nguyen Kinh

Conference Proceedings  |  2018  |  HEPATOLOGY

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Co-infected With Hepatitis C Virus and Human Immunodeficiency Virus-1: the EXPEDITION-2 Study

ME Vazquez, J Rockstroh, K Lacombe, C Orkin, A Luetkemeyer, D Wyles, R Soto Malave, KE Shermanl, R Flisiak, S Baghani, T Shimonova, J Slim, P Ruane, J Sasadeusz

Conference Proceedings  |  2018  |  International Journal of Infectious Diseases

EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR IN PATIENTS WITH HCV GENOTYPE 5 OR 6 INFECTION: THE ENDURANCE-5, 6 STUDY

Tarik Asselah, Tran Tram, Katia Alves, Nguyen Tuan, Florence Wong, Adam Mahomed, Seng Gee Lim, Samuel S Lee, Armand Abergel, Joe Sasadeusz, Preethi Krishnan, Zhenzhen Zhang, Ariel Porcalla, Roger Trinh, Edward Gane

Conference Proceedings  |  2018  |  Clinical Hepatology

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.

Drew J Winston, Kathleen M Mullane, Oliver A Cornely, Michael J Boeckh, Janice Wes Brown, Steven A Pergam, Igoris Trociukas, Pavel Žák, Michael D Craig, Genovefa A Papanicolaou, Juan D Velez, Jens Panse, Kimberly Hurtado, Doreen A Fernsler, Jon E Stek, Lei Pang, Shu-Chih Su, Yanli Zhao, Ivan SF Chan, Susan S Kaplan, et al.

Journal article  |  2018  |  The Lancet

BACKGROUND: Recipients of autologous haemopoietic stem-cell transplants (auto-HSCT) have an increased risk of herpes zoster and he..

HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome

Shu Su, Christopher K Fairley, Joe Sasadeusz, Jianmei He, Xiuqing Wei, Huan Zeng, Jun Jing, Limin Mao, Xi Chen, Lei Zhang

Journal article  |  2018  |  Journal of Medical Virology

The Role of Primary Health Care in Hepatitis B Testing and Management: A Case Study

Jacqueline A Richmond, Joe Sasadeusz, Meredith Temple-Smith

Journal article  |  2018  |  Journal of Community Health

Hepatitis B among immigrants from Myanmar: Genotypes and their clinical relevance

Thomas R Schulz, Rosalind Edwards, M Christine Thurnheer, Lilly Yuen, Margaret Littlejohn, Peter Revill, Melissa Chu, Firuz Tanyeri, Amanda Wade, Beverley-Ann Biggs, Joseph Sasadeusz

Journal article  |  2018  |  Journal of Medical Virology

HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment

Kasha P Singh, Megan Crane, Jennifer Audsley, Anchalee Avihingsanon, Joe Sasadeusz, Sharon R Lewin

Journal article  |  2017  |  AIDS

Genotypic profiles of hepatitis B in African immigrants and their clinical relevance

Maria Christine Thurnheer, Rosalind Edwards, Thomas Ray Schulz, Lilly Yuen, Margaret Littlejohn, Peter Revill, Elizabeth Bannister, Melissa Chu, Firuz Tanyeri, Amanda Wade, Beverley-Ann Biggs, Joseph Sasadeusz

Journal article  |  2017  |  JOURNAL OF MEDICAL VIROLOGY

HCV reinfection incidence among individuals treated for recent infection

M Martinello, J Grebely, K Petoumenos, E Gane, M Hellard, D Shaw, J Sasadeusz, TL Applegate, GJ Dore, GV Matthews

Journal article  |  2017  |  Journal of Viral Hepatitis

Predictors and incidence of sexually transmitted Hepatitis C virus infection in HIV positive men who have sex with men

Nicholas A Medland, Eric PF Chow, Catriona S Bradshaw, Timothy HR Read, Joseph J Sasadeusz, Christopher K Fairley

Journal article  |  2017  |  BMC INFECTIOUS DISEASES

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir /- ribavirin for hepatitis C genotype 1-final results of the REV1TAL study

John Lubel, Simone Strasser, Katherine A Stuart, Gregory Dore, Alexander Thompson, Stephen Pianko, Steven Bollipo, Joanne L Mitchell, Vincenzo Fragomeli, Tracey Jones, Sarah Chivers, Paul Gow, David Iser, Miriam Levy, Edmund Tse, Alessia Gazzola, Wendy Cheng, Saroj Nazareth, Sam Galhenage, Amanda Wade, et al.

Journal article  |  2017  |  Antiviral Therapy

Vancomycin

IC Gyssens, NE Holmes

Book Chapter  |  2017

Chloramphenicol and thiamphenicol

G MacLaren, F Shann

Book Chapter  |  2017

Artemether-lumefantrine

RJ Commons, JA Simpson, RN Price

Book Chapter  |  2017

Lamivudine

J Audsley, M Giles, SR Lewin

Book Chapter  |  2017

Benzylpenicillin (penicillin G)

AM Geddes, IM Gould, JA Roberts, JA Trubiano, M Lindsay Grayson

Book Chapter  |  2017

Discontinued hepatitis agent: Clevudine

R Chin, J Torresi, J Mills

Book Chapter  |  2017

Darunavir

AC Cheng, R Muttucumaru, SM Crowe

Book Chapter  |  2017

Foscarnet

J Mills, SM Crowe

Book Chapter  |  2017

Delavirdine

J Mills, SM Crowe

Book Chapter  |  2017

Entecavir

AC Cheng, J Sasadeusz

Book Chapter  |  2017

Indinavir

MA Boyd, SM Crowe

Book Chapter  |  2017

Discontinued herpesvirus agent: Vidarabine

SM Crowe, J Mills

Book Chapter  |  2017

Investigational antiviral drugs

J Mills, SM Crowe, M Martinello

Book Chapter  |  2017

Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs, seventh edition

ML Grayson, SE Cosgrove, SM Crowe, W Hope, JS McCarthy, J Mills, JW Mouton, DL Paterson

Book Chapter  |  2017

Artemisinins

K Thriemer, JA Simpson, JS McCarthy, RN Price

Book Chapter  |  2017

Enoxacin

PGP Charles

Book Chapter  |  2017

Rufloxacin

PGP Charles

Book Chapter  |  2017

Sparfloxacin

PGP Charles

Book Chapter  |  2017

Lomefloxacin

PGP Charles

Book Chapter  |  2017

Amdoxovir

SM Crowe, J Mills

Book Chapter  |  2017

Capreomycin

PDR Johnson

Book Chapter  |  2017

Cycloserine and terizidone

PDR Johnson

Book Chapter  |  2017

Maraviroc

M Roche, SR Lewin, PR Gorry

Book Chapter  |  2017

Pefloxacin

PGP Charles

Book Chapter  |  2017

Abacavir

PU Cameron, JA Trubiano

Book Chapter  |  2017

Ticarcillin-clavulanic acid

K Buising

Book Chapter  |  2017

Principles of antimicrobial use

ML Grayson, SE Cosgrove, SM Crowe, JS McCarthy, W Hope, J Mills, JW Mouton, DL Paterson

Book Chapter  |  2017

Apricitabine

SM Crowe, J Mills

Book Chapter  |  2017

Amantadine and rimantadine

J Mills, SM Crowe

Book Chapter  |  2017

Streptomycin

PDR Johnson

Book Chapter  |  2017

Ethionamide and prothionamide

PDR Johnson

Book Chapter  |  2017

Thiacetazone

PDR Johnson

Book Chapter  |  2017

Nelfinavir

SM Crowe, L Ostergaard, J Mills

Book Chapter  |  2017

Discontinued hepatitis agents: Torcitabine and valtorcitabine

J Mills, SM Crowe

Book Chapter  |  2017

Pyronaridine-artesunate

H Karunajeewa

Book Chapter  |  2017

Sulfonamides

NE Holmes, M Lindsay Grayson

Book Chapter  |  2017

Linezolid

SJ Sparham, BP Howden

Book Chapter  |  2017

Tosufloxacin

PGP Charles

Book Chapter  |  2017

Halofantrine

RN Price, JA Simpson, JS McCarthy

Book Chapter  |  2017

Preface

ML Grayson

Book Chapter  |  2017

Dihydroartemisinin-piperaquine

H Karunajeewa

Book Chapter  |  2017

Artesunate

RJ Commons, JA Simpson, JS McCarthy, RN Price

Book Chapter  |  2017

Trimethoprim and trimethoprim-sulfamethoxazole (cotrimoxazole)

JA Trubiano, M Lindsay Grayson

Book Chapter  |  2017

Ribavirin

E Woolnough, A Wade, J Sasadeusz

Book Chapter  |  2017

Zalcitabine

SM Crowe, J Mills

Book Chapter  |  2017

Zidovudine

CL Cherry, SM Crowe

Book Chapter  |  2017

Fosamprenavir

SM Crowe, C Katlama, R Murphy

Book Chapter  |  2017

Sofosbuvir and Ribavirin for 6 Weeks Is Not Effective Among People With Recent Hepatitis C Virus Infection: The DARE-C II Study

Marianne Martinello, Edward Gane, Margaret Hellard, Joe Sasadeusz, David Shaw, Kathy Petoumenos, Tanya Applegate, Jason Grebely, Laurence Maire, Philippa Marks, Gregory J Dore, Gail V Matthews

Journal article  |  2016  |  Hepatology

Liver Fibrosis Regression Measured by Transient Elastography in Human Immunodeficiency Virus (HIV)-Hepatitis B Virus (HBV)-Coinfected Individuals on Long-Term HBV-Active Combination Antiretroviral Therapy

Jennifer Audsley, Christopher Robson, Stacey Aitchison, Gail V Matthews, David Iser, Joe Sasadeusz, Sharon R Lewin

Journal article  |  2016  |  OPEN FORUM INFECTIOUS DISEASES

HIV and HCV Therapies in 2016: Optimal Regimens

Joe Sasadeusz

Journal article  |  2016  |  AIDS Reviews

Frequency and severity of hyperbilirubinaemia with Viekira Pak in a real-world cohort of HCV genotype 1 patients - Predictors and clinical significance

J Lubel, J Mitchell, S Pianko, A Thompson, D Iser, A Gazzola, S Chivers, G Mishra, J Gough, S Strasser, G Dore, K Stuart, J George, E Tse, A Zekry, M Levy, G Macquillan, V Fragomeli, P Gow, B Morales, et al.

Conference Proceedings  |  2016  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Excellent SVR12 rates with Viekira Pak in a real-world cohort of HCV Genotype 1 patients predominantly with cirrhosis - the Australian REV1TAL Study

John Lubel, Joanne Mitchell, Stephen Pianko, Alex J Thompson, David M Iser, Alessia Gazzola, Sarah Chivers, Gauri Mishra, John Gough, Simone I Strasser, Gregory Dore, Katherine A Stuart, Jacob George, Edmund Tse, Amany Zekry, Miriam Levy, Gerry C MacQuillan, Vince Fragomeli, Paul Gow, Brenda Morales, et al.

Conference Proceedings  |  2016  |  HEPATOLOGY

Frequency and severity of biochemical abnormalities with paritaprevir/ritonavir/ombitasvir /- ribavirin in a real-world cohort of HCV Genotype 1 patients - predictors and clinical significance

John Lubel, Joanne Mitchell, Stephen Pianko, Alex J Thompson, David M Iser, Alessia Gazzola, Sarah Chivers, Gauri Mishra, John Gough, Simone I Strasser, Gregory Dore, Katherine A Stuart, Jacob George, Edmund Tse, Amany Zekry, Miriam Levy, Gerry C MacQuillan, Vince Fragomeli, Paul Gow, Brenda Morales, et al.

Conference Proceedings  |  2016  |  HEPATOLOGY

Excellent SVR12 rates with Viekira Pak in a real-world cohort of HCV genotype 1 patients predominantly with cirrhosis - the Australian REV1TAL study

J Lubel, J Mitchell, S Pianko, A Thompson, D Iser, A Gazzola, S Chivers, G Mishra, J Gough, S Strasser, G Dore, K Stuart, J George, E Tse, A Zekry, M Levy, G Macquillan, V Fragomeli, P Gow, B Morales, et al.

Conference Proceedings  |  2016  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men

Daniel Bradshaw, Jayna Raghwani, Brendan Jacka, Rachel Sacks-Davis, Francois Lamoury, Ian Down, Garrett Prestage, Tanya L Applegate, Margaret Hellard, Joe Sasadeusz, Gregory J Dore, Oliver G Pybus, Gail V Matthews, Mark Danta

Journal article  |  2016  |  PLOS ONE

Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus Infection

Swee Lin G Chen Yi Mei, Jodie Burchell, Narelle Skinner, Rosie Millen, Gail Matthews, Margaret Hellard, Gregory J Dore, Paul V Desmond, Vijaya Sundararajan, Alexander J Thompson, Kumar Visvanathan, Joe Sasadeusz

Journal article  |  2016  |  Journal of Infectious Diseases

Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity

Jennifer Audsley, Stephen J Bent, Margaret Littlejohn, Anchalee Avihingsanon, Gail Matthews, Scott Bowden, Julianne Bayliss, Fabio Luciani, Lilly Yuen, Christopher K Fairley, Stephen Locarnini, Sharon R Lewin, Joe Sasadeusz

Journal article  |  2016  |  AIDS

Regional challenges: evaluation of a hepatitis outreach programme using transient elastography (FibroScan) in Victoria

MC Thurnheer, TR Schulz, T Nguyen, J MacLachlan, J Sasadeusz

Journal article  |  2016  |  Internal Medicine Journal

Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies

Marianne Martinello, Margaret Hellard, David Shaw, Kathy Petoumenos, Tanya Applegate, Jason Grebely, Barbara Yeung, Laurence Maire, David Iser, Andrew Lloyd, Alexander Thompson, Joe Sasadeusz, Paul Haber, Gregory J Dore, Gail V Matthews

Journal article  |  2016  |  Antiviral Therapy

Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies (vol 21, pg 425, 2016)

Marianne Martinello, Margaret Hellard, David Shaw, Kathy Petoumenos, Tanya Applegate, Jason Grebely, Barbara Yeung, Laurence Maire, David Iser, Andrew Lloyd, Alexander Thompson, Joe Sasadeusz, Paul Haber, Gregory J Dore, Gail V Matthews

Journal article  |  2016  |  Antiviral Therapy

Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study

Maria Luisa Montes, Mark Nelson, Pierre-Marie Girard, Joe Sasadeusz, Andrzej Horban, Beatriz Grinsztejn, Natalia Zakharova, Antonio Rivero, Jacques Durant, Enrique Ortega-Gonzalez, Erkki Lathouwers, Katrien Janssen, Sivi Ouwerkerk-Mahadevan, James Witek, Juan Gonzalez-Garcia

Journal article  |  2016  |  Journal of Antimicrobial Chemotherapy

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

Gregory J Dore, Brian Conway, Yan Luo, Ewa Janczewska, Brygida Knysz, Yan Liu, Adrian Streinu-Cercel, Florin Alexandru Caruntu, Manuela Curescu, Richard Skoien, Wayne Ghesquiere, Wlodzimierz Mazur, Alejandro Soza, Francisco Fuster, Susan Greenbloom, Adriana Motoc, Victoria Arama, David Shaw, Istvan Tornai, Joseph Sasadeusz, et al.

Journal article  |  2016  |  Journal of Hepatology

Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B

Michelle Giles, Kumar Visvanathan, Sharon Lewin, Scott Bowden, Stephen Locarnini, Tim Spelman, Joe Sasadeusz

Journal article  |  2015  |  GUT

Adoptive T Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cytomegalovirus Disease in a Renal Transplant Recipient

N Macesic, D Langsford, K Nicholls, P Hughes, DJ Gottlieb, L Clancy, E Blyth, K Micklethwaite, B Withers, S Majumdar, S Fleming, J Sasadeusz

Journal article  |  2015  |  American Journal of Transplantation

Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation

J Sasadeusz, HM Prince, A Schwarer, J Szer, A Stork, HL Bock, M Povey, O Nicholson, BL Innis

Journal article  |  2014  |  Transplant Infectious Disease

Guarding the sleeping giant: hepatitis B screening and management in patients with hematological malignancy

Benjamin W Teh, Joseph J Sasadeusz

Journal article  |  2014  |  Leukemia & Lymphoma

Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis.

Marisa Montes, Mark Nelson, Pierre Marie Girard, Joe Sasadeusz, Andrzej Horban, Beatriz Grinsztejn, Natalia Zakharova, Antonio Rivero, Erkki Lathouwers, Katrien Janssen, Sivi Ouwerkerk-Mahadevan, James Witek

Journal article  |  2014  |  Journal of the International AIDS Society

INTRODUCTION: We report the SVR12 final analysis of a phase 3 study of telaprevir in combination with peginterferon (P)/ribavirin ..

CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1-HBV coinfection following HBV-active antiretroviral therapy

Paola Giarda, Anchalee Avihingsanon, Joe Sasadeusz, Jennifer Audsley, Pip Marks, Gail Matthews, Kiat Ruxrungtham, Sharon R Lewin, Megan Crane

Journal article  |  2014  |  ANTIVIRAL THERAPY

Late diagnosis of human immunodeficiency virus infection in patients with viral hepatitis

M Hunter, K Clezy, KM Hajkowicz, JF Hoy, S Hume, MVN O'Sullivan, N Runnegar, J Sasadeusz, JJ Post

Journal article  |  2013  |  Internal Medicine Journal

Patterns and Causes of Suboptimal Response to Tenofovir-Based Therapy in Individuals Coinfected With HIV and Hepatitis B Virus

Gail V Matthews, Eric C Seaberg, Anchalee Avihingsanon, Scott Bowden, Gregory J Dore, Sharon R Lewin, Joe Sasadeusz, Peter A Revill, Margaret Littlejohn, Jennifer F Hoy, Robert Finlayson, Kiat Ruxrungtham, Melissa Saulynas, Stephen Locarnini, Chloe L Thio

Journal article  |  2013  |  CLINICAL INFECTIOUS DISEASES

Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals

Gail V Matthews, Rachel J Ali, Anchalee Avihingsanon, Janaki Amin, Rachel Hammond, Scott Bowden, Sharon R Lewin, Joe Sasadeusz, Margaret Littlejohn, Stephen L Locarnini, Kiat Ruxrungtham, Gregory J Dore

Journal article  |  2013  |  PLOS ONE

Beyond injecting drug use: investigation of a Victorian cluster of hepatitis C among HIV-infected men who have sex with men

Andrew A Mahony, Ellen J Donnan, Rosemary A Lester, Joseph S Doyle, James Knox, Samantha L Tracy, Scott Bowden, Joseph J Sasadeusz

Journal article  |  2013  |  Medical Journal of Australia

Non-cirrhotic portal hypertension in HIV mono-infected patients

Belinda D Jackson, Joseph S Doyle, Jennifer F Hoy, Stuart K Roberts, John Colman, Margaret E Hellard, Joseph J Sasadeusz, David M Iser

Journal article  |  2012  |  Journal of Gastroenterology and Hepatology

HIV replication is associated with increased severity of liver biopsy changes in HIV-HBV and HIV-HCV co-infection

Jennifer Audsley, Philipp du Cros, Zachary Goodman, Catriona McLean, Anne Mijch, Sharon R Lewin, Joe Sasadeusz

Journal article  |  2012  |  JOURNAL OF MEDICAL VIROLOGY

Hepatitis C treatment outcomes in Australian clinics

Heather F Gidding, Matthew G Law, Janaki Amin, George Ostapowicz, Martin Weltman, Graeme A Macdonald, Joe J Sasadeusz, Paul AW Haber, Jacob George, Gregory J Dore

Journal article  |  2012  |  Medical Journal of Australia

Effect of pegylated interferon-alpha-2a treatment on mental health during recent hepatitis C virus infection

Maryam Alavi, Jason Grebely, Gail V Matthews, Kathy Petoumenos, Barbara Yeung, Carolyn Day, Andrew R Lloyd, Ingrid Van Beek, John M Kaldor, Margaret Hellard, Gregory J Dore, Paul S Haber

Journal article  |  2012  |  Hepatology

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand

Anchalee Avihingsanon, Gail V Matthews, Sharon R Lewin, Pip Marks, Jose Sasadeusz, David A Cooper, Scott Bowden, Stephen Locarnini, Greg J Dore, Kiat Ruxrungtham

Journal article  |  2012  |  AIDS RESEARCH AND THERAPY

Factors Associated with Elevated ALT in an International HIV/HBV Co-Infected Cohort on Long-Term HAART

Jennifer Audsley, Eric C Seaberg, Joe Sasadeusz, Gail V Matthews, Anchalee Avihingsanon, Kiat Ruxrungtham, Kit Fairley, Robert Finlayson, Hyon S Hwang, Margaret Littlejohn, Stephen Locarnini, Gregory J Dore, Chloe L Thio, Sharon R Lewin

Journal article  |  2011  |  PLOS ONE

Predictors of deferral of treatment for hepatitis C infection in Australian clinics.

Heather F Gidding, Matthew G Law, Janaki Amin, Graeme A Macdonald, Joe J Sasadeusz, Tracey L Jones, Simone I Strasser, Jacob George, Gregory J Dore, undefined ACHOS investigator team

Journal article  |  2011  |  Medical Journal of Australia

OBJECTIVE: To determine uptake of treatment for hepatitis C virus (HCV) infection and predictors of deferral of treatment for HCV ..

Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection

Jason Grebely, Kathy Petoumenos, Margaret Hellard, Gail V Matthews, Vijayaprakash Suppiah, Tanya Applegate, Barbara Yeung, Phillipa Marks, William Rawlinson, Andrew R Lloyd, David Booth, John M Kaldor, Jacob George, Gregory J Dore

Journal article  |  2010  |  Hepatology

UNLABELLED: Polymorphisms in the IL28B (interleukin-28B) gene region are important in predicting outcome following therapy for chr..

Co-infection - viral hepatitis: a guide for clinical management

Book  |  2010

Chapter 3: The management of HIV and hepatitis B virus co-infection

J SASADEUSZ, B COWIE

Book Chapter  |  2010

Mycobacterium genavense duodenitis following allogeneic peripheral blood stem cell transplantation.

KJ Lu, A Grigg, D Leslie, M Finlay, J Sasadeusz

Journal article  |  2009  |  Transplant Infectious Disease

A 56-year-old man was diagnosed with Mycobacterium genavense duodenitis 21 months after an allogeneic peripheral stem cell transpl..

Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals

Gail V Matthews, Eric Seaberg, Gregory J Dore, Scott Bowden, Sharon R Lewin, Joe Sasadeusz, Pip Marks, Zachary Goodman, Frances H Philp, Yiwei Tang, Stephen Locarnini, Chloe L Thio

Journal article  |  2009  |  AIDS

Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV Coinfection

J Judy Chang, Sunee Sirivichayakul, Anchalee Avihingsanon, Alex JV Thompson, Peter Revill, David Iser, John Slavin, Supranee Buranapraditkun, Pip Marks, Gail Matthews, David A Cooper, Stephen J Kent, Paul U Cameron, Joe Sasadeusz, Paul Desmond, Stephen Locarnini, Gregory J Dore, Kiat Ruxrungtham, Sharon R Lewin

Journal article  |  2009  |  Journal of Virology

Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations

J Audsley, N Arrifin, LKW Yuen, A Ayres, SM Crowe, A Bartholomeusz, SA Locarnini, A Mijch, SR Lewin, J Sasadeusz

Journal article  |  2009  |  HIV Medicine

Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C.

GV Matthews, M Hellard, P Haber, B Yeung, P Marks, D Baker, G McCaughan, J Sasadeusz, P White, W Rawlinson, A Lloyd, J Kaldor, GJ Dore, undefined Australian Trial in Acute Hepatitis C Study Group

Journal article  |  2009  |  Clinical Infectious Diseases

BACKGROUND: The Australian Trial in Acute Hepatitis C (ATAHC) is a National Institutes of Health-funded prospective cohort study o..

HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection

JT Denholm, EJ Wright, A Street, JJ Sasadeusz

Journal article  |  2009  |  Haemophilia

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand

Gail V Matthews, Anchalee Avihingsanon, Sharon R Lewin, Janaki Amin, Rungsun Rerknimitr, Panusit Petcharapirat, Pip Marks, Joe Sasadeusz, David A Cooper, Scott Bowden, Stephen Locarnini, Kiat Ruxrungtham, Gregory J Dore

Journal article  |  2008  |  Hepatology

Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance

Scott Preiss, Margaret Littlejohn, Peter Angus, Alex Thompson, Paul Desmond, Sharon R Lewin, Joe Sasadeusz, Gail Matthews, Gregory J Dore, Tim Shaw, Vitini Sozzi, Lilly Yuen, George Lau, Anna Ayres, Chloe Thio, Anchalee Avihingsanon, Kiat Ruxrungtham, Stephen Locarnini, Peter A Revill

Journal article  |  2008  |  Hepatology

Prevalence of HSV-2 antibody in a Melbourne antenatal population attending a tertiary obstetric hospital

Joseph John Sasadeusz, Julie Elizabeth Silvers, Helen Elizabeth Kent, Wayne Devenish, Jane Hocking, Suzanne Marie Garland

Journal article  |  2008  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients

Joe Sasadeusz, Jennifer Audsley, Anne Mijch, Rachel Baden, Jose Caro, Hermeyone Hunter, Gail Matthews, Moira A McMahon, Susan A Olender, Robert F Siliciano, Sharon R Lewin, Chloe L Thio

Journal article  |  2008  |  AIDS

Hepatitis B reactivation after thalidomide

AP Grigg, J Sasadeusz

Journal article  |  2008  |  Internal Medicine Journal

Current treatment of HIV/hepatitis B virus coinfection

DM Iser, JJ Sasadeusz

Journal article  |  2008  |  Journal of Gastroenterology and Hepatology

2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study

Neil Bodsworth, Mark Bloch, Anna McNulty, Ian Denham, Nicholas Doong, Sylvie Trottier, Michael Adena, Mary-Ann Bonney, James Agnew

Journal article  |  2008  |  Sexual Health

Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.

Milos Opravil, Joe Sasadeusz, David A Cooper, Jürgen K Rockstroh, Nathan Clumeck, Bonaventura Clotet, Julio Montaner, Francesca J Torriani, Jean Depamphilis, Douglas T Dieterich

Journal article  |  2008  |  JAIDS Journal of Acquired Immune Deficiency Syndromes

OBJECTIVE: The impact of baseline CD4 status on hepatitis C virus (HCV) treatment response among patients with HIV/HCV coinfection..

2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study (vol 5, pg 219, 2008)

Neil Bodsworth, Mark Bloch, Anna McNulty, Ian Denham, Nicholas Doong, Sylvie Trottier, Michael Adena, Mary-Ann Bonney, James Agnew

Journal article  |  2008  |  Sexual Health

The anti-HIV antiviral activity of entecavir: The loss of a trusted friend?

J Sasadeusz

Journal article  |  2007  |  Journal of Hepatology

Why do we not yet have combination chemotherapy for chronic hepatitis B?

Joseph J Sasadeusz, Stephen L Locarnini, Graeme Macdonald

Journal article  |  2007  |  Medical Journal of Australia

Reduced hepatitis B virus (HBV)-specific CD4( ) T-Cell responses in human immunodeficiency virus type 1-HBV-Coinfected individuals receiving HBV-active antiretroviral therapy

JJ Chang, F Wightman, A Bartholorneusz, A Ayres, SJ Kent, J Sasadeusz, SR Lewin

Journal article  |  2005  |  Journal of Virology

A study to investigate the impact of the initiation of highly active antiretroviral therapy on the hepatitis C virus viral load in HIV/HCV-coinfected patients

A Mijch, J Sasadeusz, M Hellard, M Dunne, R McCaw, S Bowden, EJ Gowans

Journal article  |  2005  |  Antiviral Therapy

Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04.

G Boland, J Beran, M Lievens, J Sasadeusz, P Dentico, H Nothdurft, JN Zuckerman, B Genton, R Steffen, L Loutan, J Van Hattum, M Stoffel

Journal article  |  2004  |  Vaccine

The reactogenicity and safety of an experimental hepatitis B (HB) vaccine containing adjuvant system (AS04) was compared with a li..

Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patient

T Gouskos, F Wightman, J Chang, L Earnest-Silveira, J Sasadeusz, SR Lewis, J Torresi

Journal article  |  2004  |  AIDS

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

Francesca J Torriani, Maribel Rodriguez-Torres, Jürgen K Rockstroh, Eduardo Lissen, Juan Gonzalez-García, Adriano Lazzarin, Giampiero Carosi, Joseph Sasadeusz, Christine Katlama, Julio Montaner, Hoel Sette, Sharon Passe, Jean De Pamphilis, Frank Duff, Uschi Marion Schrenk, Douglas T Dieterich, undefined APRICOT Study Group

Journal article  |  2004  |  New England Journal of Medicine

BACKGROUND: Hepatitis C virus (HCV) infection is highly prevalent and is associated with substantial morbidity and mortality among..

Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART.

Anne Drake, Anne Mijch, Joe Sasadeusz

Journal article  |  2004  |  Clinical Infectious Diseases

Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection occurs commonly. The introduction of antiretroviral the..

Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?

MJ Brooks, JJ Sasadeusz, GA Tannock

Journal article  |  2004  |  Current Opinion in Pulmonary Medicine

Management of healthcare workers after occupational exposure to hepatitis C virus.

Nicola Magnavita

Journal article  |  2004  |  Medical Journal of Australia

Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus.

Doris Chibo, Julian Druce, Joe Sasadeusz, Chris Birch

Journal article  |  2004  |  Antiviral Research

We characterised the antiviral phenotype and genotype of 41 herpes simplex virus (HSV) strains from patients clinically resistant ..

Management of healthcare workers after occupational exposure to hepatitis C virus

PGP Charles, PW Angus, JJ Sasadeusz, ML Grayson

Journal article  |  2003  |  Medical Journal of Australia

Hepatitis C and pregnancy: an update.

Michelle Giles, Margaret Hellard, Joe Sasadeusz

Journal article  |  2003  |  The Australian and New Zealand Journal of Obstetrics and Gynaecology

Hepatitis C is a slowly progressive disease with significant long-term sequelae including cirrhosis, liver failure and hepatocellu..

Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals

L Cooley, A Ayres, A Bartholomeusz, S Lewin, S Crowe, A Mijch, S Locarnini, J Sasadeusz

Journal article  |  2003  |  AIDS

A cautionary tale: Fatal lactic acidosis complicating nucleoside analogue and metformin therapy

L Worth, J Elliott, J Anderson, J Sasadeusz, A Street, S Lewin

Journal article  |  2003  |  Clinical Infectious Diseases

Clinical and virological aspects of hepatitis B co-infection in individuals infected with human immunodeficiency virus type-1.

Louise Cooley, Joseph Sasadeusz

Journal article  |  2003  |  Journal of Clinical Virology

The improved prognosis of HIV-infection that has occurred since the introduction of highly active antiretroviral therapy (HAART) h..

Successful allogeneic stem cell transplant after invasive pulmonary zygomycosis

MA Slavin, K Kannan, MR Buchanan, J Sasadeusz, AW Roberts

Journal article  |  2002  |  Leukemia and Lymphoma

Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child

P Bryant, J Sasadeusz, J Carapetis, K Waters, N Curtis

Journal article  |  2001  |  Pediatric Infectious Disease Journal

Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones.

J Sasadeusz

Journal article  |  2001  |  Internal Medicine Journal

Recent successes in HIV therapy have uncovered other health problems for HIV-infected individuals. Hepatitis C has become an espec..

Abnormal cervical cytology in bone marrow transplant recipients

J Sasadeusz, H Kelly, J Szer, AP Schwarer, H Mitchell, A Grigg

Journal article  |  2001  |  Bone Marrow Transplantation

Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir

CB Steer, J Szer, J Sasadeusz, JP Matthews, JA Beresford, A Grigg

Journal article  |  2000  |  Bone Marrow Transplantation

HSV resistance

JJ Sasadeusz

Journal article  |  1998  |  Herpes

Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.

JJ Sasadeusz, F Tufaro, S Safrin, K Schubert, MM Hubinette, PK Cheung, SL Sacks

Journal article  |  1997  |  Journal of virology

In the majority of cases, the mechanism underlying the resistance to acyclovir (ACV) of herpes simplex viruses (HSVs) is thymidine..

Spontaneous reactivation of thymidine kinase-deficient, acyclovir-resistant type-2 herpes simplex virus: masked heterogeneity or reversion?

JJ Sasadeusz, SL Sacks

Journal article  |  1996  |  Journal of Infectious Diseases

Herpes simplex virus (HSV) strain 1737, acyclovir-resistant and uniformly thymidine kinase-deficient (tkD) by all conventional ass..

Herpes latency, meningitis, radiculomyelopathy and disseminated infection.

JJ Sasadeusz, SL Sacks

Journal article  |  1994  |  Genitourinary Medicine

Herpes latency, meningitis, radiculomyelopathy and disseminated infection

JJ Sasadeusz, SL Sacks

Journal article  |  1994  |  Sexually Transmitted Infections

Systemic antivirals in herpesvirus infections.

JJ Sasadeusz, SL Sacks

Journal article  |  1993  |  Dermatologic Clinics

Over the last few years we have seen the advent of effective antiviral drug therapy, the major ramifications being in the area of ..

Reactive haemophagocytic syndrome in human immunodeficiency virus infection.

J Sasadeusz, M Buchanan, B Speed

Journal article  |  1990  |  Journal of Infection

The reactive or virus-associated haemophagocytic syndrome (RHS) has been described in association with several different infection..